Institut Für Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest

This study tested a drug called sacituzumab-govitecan in 58 people with advanced stomach cancer that had spread to other parts of the body. The drug targets a protein on cancer cells to deliver chemotherapy directly. The goal was to see if the drug could shrink tumors or slow the…

This study tested a combination of targeted radiation and an immunotherapy drug (durvalumab) in 51 elderly or frail patients with stage III lung cancer who could not tolerate standard chemotherapy. The goal was to see if this approach is safe and can shrink tumors. Results showed…

This study tested a combination of two drugs, fedratinib and nivolumab, in 30 adults with myelofibrosis whose disease no longer responded well to standard JAK-inhibitor treatment. The goal was to see if the combination could shrink the spleen, improve symptoms, or reduce the need…

This study tested whether giving the immunotherapy drug pembrolizumab before and after a standard tumor-destroying procedure (ablation) could improve outcomes for 30 people with early-stage liver cancer. The goal was to see if the combination could shrink tumors and delay recurre…

This study created a registry of 159 adults with biliary tract cancer (including gallbladder cancer) in Germany. Researchers collected information on medical history, treatments, and quality of life to better understand the disease and help design future studies. No new treatment…